Nadia studied Natural Sciences (biochemistry) during her undergraduate and Masters degrees at Cambridge University. Her PhD was on a novel family of tumour suppressor proteins at the Ludwig Institute for Cancer Research, Imperial College, London after which she did a postdoctoral research fellowship focused on acquired resistance to EGFR therapy in lung cancer at Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston. She then moved back to the UK to do a second postdoctoral fellowship at Cancer Research UK (now the Francis Crick Institute) to identify novel regulators of anoikis and metastasis. Nadia joined Synexa in 2015 to set up the Oncology lab with a particular focus on Liquid Biopsies.
Following his under- and post-graduate education in molecular genetics and biochemistry at the Universities of the Freestate and Stellenbosch respectively, Matti worked for 4 years at the Institute for Infectious Disease and Molecular Medicine (IIDMM) at the University of Cape Town. With the move from molecular biology to immunology, Matti’s research at the IIDMM explored the role of various innate receptors in murine models of cancer immunotherapy and infection. Driven by a passion for applying scientific knowledge to improve medical outcomes, Matti joined Synexa early in early 2011. His role as Lead Scientist includes the development of tailor-made biomarker strategies and assays that are scientifically sound and provide optimal insight into drug safety and efficacy.
Andreia is a cellular immunologist with extensive experience in advanced immunological techniques, such as multiparameter flow cytometry. She brings with her a unique perspective on biomarker discovery with her background in infectious diseases and clinical immunology. Andreia completed her PhD in Clinical Science and Immunology at the University of Cape Town, which focused on Bacille Calmette Guérin (BCG)-specific T cell mediated immunity following vaccination of newborns. The predominant focus of her post-doctoral work was on new vaccination strategies against HIV. Andreia has several international peer-reviewed publications related to HIV and TB and her area of interest is focused on attaining a better understanding of cellular immunity related to infectious diseases and vaccine induced immune responses.